N@N

Noveko Wins a First Contract for its Noveko IDP(TM) Filters with Air Transat

^{Published on 2011-06-29 06:35:51 - Market Wire}
 

MONTREAL, June 29 /CNW Telbec/ - Noveko International Inc. (TSX: EKO) (the "Company") is pleased to announce that its subsidiary Noveko Inc. ("Noveko") has been awarded a firm order by Air Transat, Canada's leading holiday travel airline, to equip Air Transat's entire fleet of Airbus A330 with its Noveko IDP(TM) filters.

Air Transat's fleet comprises 21 aircraft, including ten Airbus A330s currently in operation. Two more A330s will be added to its fleet by the beginning of 2012. Each aircraft of this series generally requires eight air filters.

"We are very pleased that Air Transat is our first client and officially marks our breakthrough in the aeronautics market. This order is a true recognition of the value of our patented air filtration technologies, as Air Transat supported us in the process of obtaining the certification required to install our filters in their A330 long-haul aircraft. We are delighted to keep up this momentum and to further intensify our partnership," indicated Mr. Alain Bolduc, President and Chief Operating Officer of the Company.

"To remain the leader in our category, we always make sure we carefully select each of our suppliers. We were impressed with the performance of the filters, as they attain exceptional ULPA (Ultra-Low Particulate Air) filtration levels, and their useful life is almost twice as long as traditional filters. We therefore selected Noveko IDP(TM) filters for their high value-added features, including their antimicrobial technologies, which protect the filters against the deterioration caused by microorganisms, and their anti-odour technologies, thereby enabling us to provide our passengers and employees with better air quality," added Mr. Allen B. Graham, President and Chief Executive Officer of Air Transat.

This breakthrough by Noveko in the aeronautics market follows Transport Canada's grant earlier this month of a Supplemental Type Certificate (or "STC") for Noveko IDP(TM) filters, paving the way for their commercialization throughout the Airbus 330 fleet worldwide. Exhibited for the first time at last week's International Paris Air Show at Le Bourget, these filters are attracting growing interest in the industry.

Profiles

Air Transat is Canada's leading holiday travel airline. The Company carries some 3 million passengers annually. Air Transat currently has a fleet of 21 Airbus A330s and A310s and two Airbus A330s will be added to its fleet by the beginning of 2012. Air Transat is a subsidiary of Transat A.T. Inc., an integrated international tour operator with more than 60 destination countries that distributes products in over 50 countries. A holiday travel specialist, Transat operates mainly in Canada and Europe, as well as in the Caribbean, Mexico and the Mediterranean Basin. Montreal-based Transat is also active in air transportation, hotel accommodation, destination services and distribution.

Noveko International Inc. offers innovative solutions in the environmental and medical fields worldwide. Through its subsidiaries, the Company specializes primarily in the following business segments: the development, manufacturing and marketing of derivative products from its patented antimicrobial filtration technologies, mainly air filters, surgical masks and respirators, as well as other products with antibacterial properties such as hand sanitizers - and the development, manufacturing and marketing of medical equipment, primarily portable real-time ultrasound scanners for use in human and veterinary medicine.

Certain statements set forth in this press release constitute forward-looking statements. In some cases, these statements are identified by the use of terms such as "may", "could", "might", "intend", "should", "expect", "project", "plan", "believe", "estimate" or other comparable variants. These statements are based on the information available at the time they are written, on assumptions made by management and on the expectations of management, acting in good faith, regarding future events, including those relating to economic conditions, fluctuations in exchange rates and operating expenses, and the absence of unusual events entailing supplementary expenditures. Although management considers these assumptions and expectations reasonable based on the information available at the time they are written, they could prove inaccurate. Forward-looking statements are also subject, by their very nature, to known and unknown risks and uncertainties such as those related to the industry, acquisitions, labor relations, credit, key officers, supply and product liability. The actual results of Noveko International Inc. could differ materially from those indicated or underlying these forward-looking statements. The reader is therefore recommended not to unduly rely on these forward-looking statements. Forward-looking statements do not reflect the potential impact of special items, any business combination or any other transaction that may be announced or occur subsequent to the date hereof. Unless otherwise required under securities laws, the Company does not intend and undertakes no obligation to update or revise the forward-looking statements.